Cantor Fitzgerald’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-125,667
Closed -$1.17M 505
2025
Q2
$1.17M Buy
125,667
+85,667
+214% +$748K 0.02% 142
2025
Q1
$390K Buy
+40,000
New +$495K 0.01% 167
2024
Q3
Sell
-145,919
Closed -$1.31M 289
2024
Q2
$1.31M Buy
+145,919
New +$1.02M 0.26% 63

Other funds holding REPL

Cantor Fitzgerald's REPL Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 125,667 shares — an estimated $1.17M sold.

Cantor Fitzgerald first reported a position in REPL in Q2 2024 and held it in 3 quarters. The position peaked at $1.31M in Q2 2024. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 125,667 Replimune Group shares in Q3 2025, an estimated $1.17M.
  • Cantor Fitzgerald first reported a position in Replimune Group in Q2 2024 and held it in 3 quarters.
  • Cantor Fitzgerald's Replimune Group position peaked at $1.31M in Q2 2024.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.